Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov ID: NCT01268072

Public ClinicalTrials.gov record NCT01268072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 10:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Observational Study to Evaluate Biomarkers in Acute Exacerbations in Chronic Obstructive Pulmonary Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPD

Study identification

NCT ID
NCT01268072
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
MedImmune LLC
Industry
Enrollment
61 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Nov 2012 (Actual)
Completion
Jan 2013 (Actual)
Last update posted
Feb 20, 2013

2011 – 2013

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Research Site Baltimore Maryland 21201 —
Research Site Springfield Massachusetts 01199 —
Research Site St Louis Missouri 63110 —
Research Site Buffalo New York 14215 —
Research Site Cincinnati Ohio 45267 —
Research Site Philadelphia Pennsylvania 19140 —
Research Site Pittsburgh Pennsylvania 15213 —
Research Site Providence Rhode Island 02903 —
Research Site Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01268072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2013 · Synced Oct 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01268072 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →